company history

Fibroplate is the distribution Company for Fibrinogen coated Albumin Spheres. The success of Fibrinogen coated Albumin Spheres is the result of 35 years of research conducted by Dr. Yen, using the inventor's own fundings.

Work conducted independently at a leading University has confirmed a 60% survival rate in mice exposed to lethal doses of irradiation which are treated with the company product, due to less internal bleeding. This is compared to the control group of 5% survival.

Subsequently the company began to focus its effort on the treatment of radiation induced skin injury.